Meridian Bioscience (VIVO)
Create an AlertMeridian Bioscience News
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® Mycoplasma
Business Wire Jun 10Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia , its fourth assay on the illumigene platform.
Friday 5/3 Insider Buying Report: HTCH, VIVO
May 3As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Hutchinson Technology (HTCH), a filing with the SEC revealed that on Thursday, Director [...]
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio
Benzinga Apr 30Top Ranked Dividend Stock VIVO Enters Oversold Territory
Apr 26The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.
Craig-Hallum Downgrades Meridian Biosciences (VIVO) to Hold
Street Insider Apr 26Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| VIVO | 21.72 | +0.22 | +1.02% | 900.67M |
